£42.00Tax includedLowest price in 30 days: £42.00
In stock
Orders placed before 4 pm are shipped on the same day
Hammer Labz BAM-15 is an advanced single-ingredient research formula containing 15 mg of BAM-15 per capsule, with 30 capsules and 30 individually measured servings in every bottle.
BAM-15 is a specialist compound that has attracted significant attention in metabolic and mitochondrial research. Unlike conventional stimulant-based fat burners, BAM-15 has been investigated as a mitochondrial uncoupler—a compound capable of altering the efficiency with which mitochondria convert nutrient-derived energy into ATP.
This has made BAM-15 particularly interesting within research exploring:
Importantly, the published evidence remains primarily preclinical, including cell-culture and animal studies. BAM-15 does not currently have an established clinical dosage or well-characterised long-term human safety profile.
Most mainstream thermogenic products are built around compounds that stimulate the central nervous system.
Typical stimulant-based formulas may contain ingredients such as caffeine, yohimbine or other adrenergic compounds that primarily work by increasing alertness and sympathetic activity.
BAM-15 has a fundamentally different research profile.
Instead of primarily stimulating the nervous system, BAM-15 has been studied for its ability to affect mitochondrial energy coupling.
Mitochondria normally convert energy from carbohydrates and fats into ATP, which cells use as their primary energy source.
BAM-15 acts as a protonophore in experimental models, allowing some of the mitochondrial proton gradient to dissipate independently of ATP synthase. This means nutrient oxidation can increase without an equivalent increase in ATP production.
In simple terms, the mitochondria may need to process more fuel to produce the same usable cellular energy.
This mechanism is the primary reason BAM-15 has become an important experimental compound in metabolic research.
BAM-15 is the abbreviated name commonly used for:
N5,N6-bis(2-fluorophenyl)-[1,2,5]oxadiazolo[3,4-b]pyrazine-5,6-diamine
It was identified during research into compounds capable of selectively uncoupling mitochondrial respiration without producing some of the cellular effects associated with older mitochondrial uncouplers.
Early laboratory research found that BAM-15 increased mitochondrial oxygen consumption while having relatively limited effects on plasma membrane potential under the tested experimental conditions.
This distinction made BAM-15 particularly interesting as a research tool for investigating mitochondrial metabolism.
Mitochondria generate ATP through oxidative phosphorylation.
Normally, nutrients are broken down and electrons move through the mitochondrial electron transport chain. This process pumps protons across the inner mitochondrial membrane, creating a proton gradient.
ATP synthase then uses this gradient to manufacture ATP.
A mitochondrial uncoupler partially separates—or “uncouples”—these two processes.
Instead of every proton travelling back through ATP synthase, some protons return across the membrane through an alternative pathway.
This can increase:
while reducing the efficiency with which chemical energy is stored as ATP.
That inefficiency is exactly what makes mitochondrial uncoupling scientifically interesting in obesity and metabolic-disease research.
One of the most significant areas of BAM-15 research involves energy expenditure.
In animal studies, BAM-15 increased nutrient oxidation and energy expenditure without requiring a reduction in food intake.
This is scientifically important because conventional weight-loss interventions usually depend on eating fewer calories, increasing physical activity or both.
In experimental models, mitochondrial uncoupling provides a third mechanism: increasing the amount of energy required to maintain cellular function.
A 2020 study reported that BAM-15-treated mice showed increased nutrient oxidation and reduced fat mass while maintaining lean mass and food intake. These effects were observed in a controlled animal model and should not be interpreted as confirmed human outcomes.
BAM-15 has received particular attention because of findings involving adiposity in rodent models.
Researchers have reported:
Importantly, some studies reported these effects without major reductions in lean body mass.
This is one of the reasons BAM-15 is often discussed differently from conventional stimulant-based fat-loss compounds.
However, these findings come from animal models. There are no large controlled human trials demonstrating that 15 mg or any other oral amount produces the same effects in people.
One of the clearest biological effects reported in preclinical studies is increased nutrient oxidation.
When mitochondrial efficiency decreases, cells can require greater substrate turnover to maintain energy production.
Potential substrates include:
In experimental models, BAM-15 increased mitochondrial respiratory activity and stimulated the oxidation of available nutrients.
This has led researchers to investigate BAM-15 in relation to obesity, insulin resistance and fatty-liver disease.
Animal research has also examined BAM-15 in relation to glucose regulation and insulin action.
In diet-induced obesity models, researchers reported improvements in:
These findings are particularly relevant because mitochondrial dysfunction is strongly associated with several metabolic disorders.
However, BAM-15 has not been established as a treatment for diabetes or insulin resistance in humans.
Anyone with diabetes or taking glucose-lowering medication should not use experimental compounds as a substitute for prescribed treatment.
Preclinical studies have reported reductions in hepatic lipid accumulation following BAM-15 treatment.
Fat accumulation within the liver is a major feature of metabolic dysfunction and is associated with obesity and insulin resistance.
Research into mitochondrial uncouplers has therefore explored whether increasing hepatic nutrient oxidation could reduce excessive lipid storage.
BAM-15 has shown promising effects in these experimental models, but this does not establish treatment efficacy for human fatty-liver disease.
| Feature | BAM-15 | Traditional Stimulant Fat Burner |
|---|---|---|
| Primary Research Mechanism | Mitochondrial uncoupling | Central nervous system stimulation |
| Caffeine | None listed | Often included |
| Main Research Interest | Energy expenditure and nutrient oxidation | Alertness and thermogenesis |
| Direct Stimulant Effect | Not its primary mechanism | Common |
| Appetite Suppression | Not the principal research mechanism | Frequently targeted |
| Human Clinical Evidence | Very limited | Depends on ingredient |
| Mitochondrial Research | Extensive preclinical interest | Usually secondary |
| Experimental Status | High | Varies |
BAM-15 should therefore not be expected to feel like a high-stimulant thermogenic formula.
Its appeal comes primarily from its experimental metabolic mechanism rather than an immediate stimulant sensation.
Mitochondrial uncoupling is biologically powerful.
ATP production is essential for almost every tissue in the body, including:
Excessive mitochondrial uncoupling can therefore be dangerous.
Older uncoupling agents demonstrate why this mechanism cannot be treated casually. BAM-15 was developed partly because researchers were seeking uncouplers with a wider experimental safety window and fewer off-target effects.
This does not mean BAM-15 has been proven safe for unrestricted human use.
Human toxicology, dose escalation, pharmacokinetics and long-term safety remain inadequately characterised.
| Product Detail | Specification |
| Brand | Hammer Labz |
| Product | BAM-15 |
| Active Ingredient | BAM-15 |
| Strength | 15 mg per capsule |
| Capsules | 30 |
| Servings | 30 |
| Formula Type | Single ingredient |
| Caffeine | None listed |
| Research Category | Mitochondrial metabolism |
Hammer Labz BAM-15 is intended for experienced adults already familiar with advanced research compounds.
It may be of interest to users researching:
It is not positioned as an entry-level fat burner or a conventional everyday sports supplement.
BAM-15 is an experimental mitochondrial uncoupler with limited human safety data.
Do not use if you are under 18, pregnant or breastfeeding.
Consult a qualified healthcare professional before considering use if you:
Do not combine experimental metabolic compounds without appropriate professional guidance.
Keep out of reach of children.
Store in a cool, dry place away from direct sunlight.
| Research Area | Finding | Evidence Level |
| Mitochondrial respiration | BAM-15 increased mitochondrial oxygen consumption | Cell research |
| Nutrient oxidation | Increased substrate oxidation | Animal research |
| Energy expenditure | Increased energy expenditure reported | Animal research |
| Body-fat reduction | Reduced fat mass in obese mice | Animal research |
| Lean mass | Lean mass was maintained in selected models | Animal research |
| Insulin sensitivity | Improved in multiple tissues | Animal research |
| Liver fat | Reduced hepatic lipid accumulation | Animal research |
| Human weight loss | Not established | No robust clinical evidence |
| Human dosage | Not established | Insufficient evidence |
| Long-term safety | Not established | Insufficient evidence |
No. BAM-15 is not primarily researched as a central nervous system stimulant.
Its main research mechanism involves mitochondrial uncoupling and increased nutrient oxidation rather than caffeine-like stimulation.
BAM-15 reduced fat mass and increased energy expenditure in animal models.
These results are promising from a research perspective, but they do not prove the same degree of fat loss in humans.
Appetite suppression is not considered its primary mechanism.
In several animal studies, BAM-15 reduced body-fat accumulation without substantially reducing food intake, suggesting that increased energy expenditure rather than reduced calorie consumption played a major role.
Both are discussed within the broad field of mitochondrial uncoupling, but they are chemically different compounds.
BAM-15 was investigated partly because researchers were seeking compounds capable of producing mitochondrial uncoupling with fewer unwanted cellular effects than older uncouplers.
This does not establish that BAM-15 is safe or equivalent to a clinically approved fat-loss treatment.
An increase in energy expenditure can theoretically increase heat production, but controlled human data describing the frequency or intensity of thermogenic effects are unavailable.
The absence of stimulant ingredients does not mean mitochondrial uncoupling is physiologically inactive.
Selected mouse studies reported reduced fat mass without significant loss of lean mass.
Whether this occurs in humans has not been established through controlled clinical trials.
Human safety has not been adequately established.
BAM-15 showed a promising experimental safety profile in several preclinical studies, but animal tolerability cannot establish long-term safety in humans
There is no clinically validated human dosage.
Hammer Labz provides 15 mg per capsule, but this is a product serving amount rather than a medically established dose.
BAM-15 is better classified as an advanced experimental metabolic compound than a beginner-friendly fat burner.
Users unfamiliar with mitochondrial uncouplers should not treat it like a standard caffeine-based thermogenic supplement.
The research base is currently dominated by cell and animal studies.
Robust controlled human trials establishing weight-loss efficacy, dosage, pharmacokinetics and long-term safety are not available.
Cross The Limits is the exclusive UK distributor of Hammer Labz, bringing you direct access to one of the most advanced hardcore supplement brands on the market.
Hammer Labz is known for producing high-performance formulas designed for serious athletes, combining cutting-edge ingredients with aggressive dosing to deliver real results in strength, energy, endurance, and body composition.
This partnership positions Cross The Limits as the go-to destination in the UK for Hammer Labz supplements, trusted by customers seeking hardcore, results-driven formulas that stand out from standard offerings.
No product reviews yet — add the first one!